CORD-19:8c51cf0cc444f6a851ad178040369984759ddfec / 16069-16204
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/8c51cf0cc444f6a851ad178040369984759ddfec","sourcedb":"CORD-19","sourceid":"8c51cf0cc444f6a851ad178040369984759ddfec","text":"The third group of retinopathies associated with antiretinal antibodies is classified as the retinal degenerative disorders (Table 4) .","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T131","span":{"begin":0,"end":135},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T131","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T56","span":{"begin":0,"end":135},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T56","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T131","span":{"begin":0,"end":135},"obj":"Sentence"}],"attributes":[{"subj":"T131","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T125","span":{"begin":101,"end":123},"obj":"Disease"},{"id":"T97300","span":{"begin":101,"end":123},"obj":"Disease"}],"attributes":[{"id":"A125","pred":"mondo_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/MONDO_0024236"},{"id":"A56803","pred":"mondo_id","subj":"T97300","obj":"http://purl.obolibrary.org/obo/MONDO_0024236"},{"subj":"T125","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T97300","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecb193","default":true},{"id":"Epistemic_Statements","color":"#9793ec"},{"id":"CORD-19_Custom_license_subset","color":"#a8ec93"},{"id":"CORD-19-PD-MONDO","color":"#ec93c2"}]}]}}